查找临床试验
已按「肝癌」检索，对应国际通用词 hepatocellular carcinoma
共找到 357 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:13，每 5 分钟自动同步正在招募II 期中国有中心NCT06954116
Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence
China
年龄 18 Years – 75 Years
Tongji Hospital
正在招募II 期中国有中心NCT07806292
Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study
China
年龄 18 Years – 75 Years
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
正在招募不适用中国有中心NCT07557225
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
China
年龄 18 Years – 不限
Peking University First Hospital
正在招募II 期中国有中心NCT07327788
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
China
年龄 18 Years – 不限
Nanfang Hospital, Southern Medical University
正在招募不适用中国有中心NCT06219096
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
China
年龄 18 Years – 75 Years
West China Hospital
正在招募不适用中国有中心NCT06430983
Recurrent Liver Cancer: Reconceptualization and Reevaluation
China
年龄 18 Years – 75 Years
Nanjing Medical University
正在招募不适用中国有中心NCT06060769
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
China
年龄 18 Years – 不限
Fifth Affiliated Hospital, Sun Yat-Sen University
正在招募II 期中国有中心NCT07560566
SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin
Taiwan
年龄 18 Years – 不限
National Taiwan University Hospital
正在招募不适用中国有中心NCT06653062
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
China
年龄 18 Years – 不限
Tongji Hospital
正在招募不适用中国有中心NCT07839767
Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence
Hong Kong
年龄 18 Years – 不限
The University of Hong Kong
正在招募I 期 / II 期NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
正在招募不适用中国有中心NCT06909708
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
China
年龄 18 Years – 不限
Zhongda Hospital